+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Genetic Technology-Patent Trends across Gene Editing

  • ID: 4013045
  • Report
  • February 2016
  • Region: Global
  • 15 pages
  • Frost & Sullivan
1 of 2

Enquire about COVID-19 updates for this product.

Enquire Now
This edition of the Genetic Technology Technology Opportunity Engine (TOE) depicts the current landscape and the new life sciences trends across Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) gene editing mechanisms and cell therapies. The study covers the institutions involved in the CRISPR patent battle and the licensing agreements evolved through CRISPR-Cas9 patent scenario, as well as, the first stem cell-based therapy approved in Europe and antigen-specific T cell platforms for development of cell therapies. The corresponding analyst insights on gene editing patents, the overall patent scenario, along with the industry interactions, are exhibited.

The Genetic Technology TOE presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Note: Product cover images may vary from those shown
2 of 2
Trend-Based Technology Profiles
  • Institutions Involved in the CRISPR Patent Battle
  • License Agreements Evolved through CRISPR-Cas9 Patent Scenario
  • Repercussions of CRISPR Patent Battle across other Regions
  • Innovations that Stemmed off CRISPR- Cas9
Strategic Perspectives
  • Strategic Perspectives
  • Patent Scenario
  • Industry Interactions
Note: Product cover images may vary from those shown